GENZYME IRELAND LIMITED

Genzyme Ireland Limited – a subsidiary of Sanofi – is an R&D‑driven, AI‑powered biopharmaceutical company operating from Ireland. Leveraging Sanofi’s global science platform, Genzyme Ireland focuses on the discovery and development of innovative medicines and vaccines across key therapeutic areas, including immunology, neurology, oncology, rare diseases and vaccines.

The company combines cutting‑edge digital and artificial‑intelligence tools with robust manufacturing and supply capabilities to accelerate the pipeline from laboratory to market. Through extensive clinical‑trial programmes, external innovation partnerships and out‑licensing arrangements, Genzyme Ireland works with academic institutions, biotech partners and health‑system stakeholders to bring breakthrough treatments to patients.

Genzyme Ireland is committed to sustainable, equitable access to healthcare, minimising environmental impact and enhancing health‑system resilience. Its primary customers are patients worldwide, clinicians and health‑care providers, while it also serves investors, research collaborators and industry partners seeking advanced therapeutic solutions.